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The cholesterol receptor-binding drugs amphotericin B and digitonin reduced
rickettsial plaque formation, presumably by blocking rickettsial attachment, even
when added to the plaque model on day 4 post-inoculation when infected foci
were well established. The phospholipase inhibitor phentermine reduced plaque
formation, presumably by inhibiting the phospholipase-associated entry step of
penetration.
Although there is strong evidence in the
plaque model that Rickettsia rickettsii has the
capacity to injure cells directly (7, 8), the patho-
genic mechanism is obscure. Studies by Winkler
and co-workers of rickettsial hemolysis have
elucidated the interaction of Rickettsia prowaze-
kii and the host cell membrane, which is the
probable basis for rickettsial penetration and
host cell membrane injury (3-5, 9, 13-15, 17).
The lysis of sheep erythrocytes and the penetra-
tion of eucaryotic host cells by R. prowazekii
appear to require rickettsial attachment to a
cholesterol-containing host cell membrane re-
ceptor, rickettsial metabolic activity, host cell
metabolic activity, and phospholipase A activi-
ty. Inoculation of L-cell monolayers with R.
prowazekii at a large multiplicity of infection
induces immediate cytotoxicity associated with
phospholipase activity and hydrolysis of fatty
acids from host cell phospholipids (16). Our
study extends the evidence for cell membrane
injury by the phospholipase-associated penetra-
tion mechanism to R. rickettsii, the etiological
agent of Rocky Mountain spotted fever; to the
plaque model, which mimics actual infection
more closely than the hemolysis or immediate
cytotoxicity phenomenon; and to the use of a
phospholipase inhibitor as a tool for evaluating
rickettsial pathogenesis.
Rickettsial plaque assays were performed by
the methods of Wike and Burgdorfer (10) and
Wike et al. (11, 12). R. rickettsii (Sheila Smith
strain) and primary chicken embryo cell mono-
layers prepared from antibiotic-free, specific-
pathogen-free eggs overlaid with 4 ml of medium
199 (GIBCO Laboratories, Grand Island, N.Y.)
containing 5% fetal calf serum and 0.5% agarose
were used in experiments A and B, and Vero
cells overlaid with minimal essential medium
(GIBCO) containing 5% fetal calf serum, 10%
tryptose phosphate broth, and 0.5% agarose
were used in experiments C and D.
Experiment A was designed to evaluate the
effect of the addition of compounds which bind
to the cholesterol-containing receptor for rick-
ettsiae in the host cell membrane on the expres-
sion of cell injury, i.e., plaque formation. After
incubation of R. rickettsii-infected monolayers
for 4 days, which allowed the establishment of
foci of rickettsial infection, subsequent overlays
of medium were added to maintain the following
concentrations of active cholesterol receptor-
binding drugs: amphotericin B, 5 or 10 ,ug/ml (4
and 5 flasks, respectively), or digitonin, 5 ,ug/ml
(10 flasks). Because the half-life of antifungal
activity of amphotericin B in complex culture
media is approximately 24 h (1), second and
third overlays of 4 ml of medium containing 2.5
and 5.0 ,ug of amphotericin B per ml were added
to the flasks containing 5 and 10 ,ug of the drug
per ml, respectively, on days 5 and 6 after
incubation of rickettsiae. Cholesterol receptor-
binding drugs reduced the quantities of plaques
on day 6 after inoculation but not on day 7 when
the drugs were no longer being replenished
(Table 1).
The effectiveness of amphotericin B and digi-
tonin at 6 days but not at 7 days suggests that the
equilibrium between bound cholesterol-contain-
ing receptors and free receptors shifted toward
the latter. This was possibly due to the decay of
active cholesterol-binding drugs and possibly
due to the replacement of receptors by cell
membrane biosynthesis. The use of two different
cholesterol-binding drugs indicated that plaque
reduction was not due to some other nonspecific
effect of these compounds.
Experiments B, C, and D were designed to
evaluate the effect that the incorporation of the
phospholipase inhibitor phentermine (6) into the
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TABLE 1. Effect of cholesterol-binding drugs on
plaque formation by R. rickettsii
Mean no. of plaques (tSE)
Treatment
Day 6 Day 7
Amphotericin B 14 (±2.3)a 22 (t2.6)
(5 ALg/mI)
Amphotericin B 14 (t2.6)b 24 (±3.3)
(10 ,ug/ml)
Digitonin (5 ,uag/ml) 15 (t2.8)a 27 (±3.5)
None 25 (±2.9) 28 (t3.0)
a Differs from controls; one-tailed P value, 0.02 by
Wilcoxon two-sample test.
b Differs from controls; one-tailed P value, 0.01 by
Wilcoxon two-sample test.
overlay medium had on plaque formation. In
experiment B, phentermine time-release cap-
sules (Beecham Laboratories, Bristol, Tenn.)
were incorporated into the first overlay medium
on day 0 and the second overlay medium on day
4 in the following final concentrations: 0.01,
0.05, 0.1, and 0.5 mg/ml. There were six flasks
for each phentermine concentration and six
flasks without phentermine. In experiment C,
phentermine hydrochloride tablets (Beecham
Laboratories) were dissolved and incorporated
into the overlay medium on days 0 and 4 in the
following concentrations: 0.01 (15 flasks), 0.05
(16 flasks), and 0.1 (8 flasks) mg/ml. Because 0.5
mg of dissolved phentermine salt per ml was
toxic to the overlay in experiment C, presum-
ably because of a higher concentration of phen-
termine than in the resin, phentermine salt was
incorporated into both overlays in experiment D
in the following concentrations: 0 (20 flasks),
0.01 (17 flasks), 0.05 (16 flasks), 0.1 (16 flasks),
and 0.15 (17 flasks) mg/ml.
In each phentermine experiment, there was a
highly statistically significant reduction in
plaques on day 6 and a linear dose-response
relationship between the concentration of phen-
termine and plaque reduction by both analysis of
variance, using orthogonal polynomials (P <
0.0001), and Jonckheere's test (P < 0.0001) (2)
(Table 2).
Our observation that plaque reduction results
from blocking the adsorption of R. rickettsii to
cholesterol-containing receptors suggests that
rickettsial penetration is necessary for the
expression of cytopathic effect by the rickettsi-
ae. That plaque reduction results from the pres-
ence of a phospholipase inhibitor suggests that
activity of this enzyme is also required for the
expression of cytopathic effect by the rickettsi-
ae. The dose-response relationship between
phentermine concentration and plaque reduction
further supports the hypothesis that phospholi-
pase activity plays an important role in the
TABLE 2. Effect of phentermine on plaque
formation by R. rickettsii
Phentermine
concn in Mean no. of plaques (±SE)
overlay
medium Expt B Expt C Expt D
0.01 126 (±10.5) 86 (±3.5) 100 (±3.7)
0.05 138 (±11.2) 92 (±4.4) 96 (±5.3)
0.10 85 (±7.1) 73 (±2.3) 80 (±5.6)
0.15 NTa NT 77 (±4.6)
0.50 57 (±3.7) Tb NT
None 189 (±6.9) 116 (+4.9) 129 (±5.5)
a NT, Not tested.
b T, Phentermine salt toxic to cell monolayer at this
concentration.
pathogenesis of cell injury by R. rickettsii. Doc-
umentation that inhibition of either of the two
steps of the penetration mechanism, adsorption
and entry, reduces the expression of the cyto-
pathic effect of R. rickettsii is compelling evi-
dence that the phospholipase-associated pene-
tration mechanism is essential for cell injury and
may, in fact, be the mechanism of cell injury by
rickettsiae. The reduction in plaque formation
by the addition of either of two cholesterol-
receptor binding drugs after 4 days of incuba-
tion, during which time infected foci become
well established, is strong support for the prem-
ise that the cytopathic effect itself is inhibited
rather than merely that the initial infection is
prevented.
Moreover, these studies extend our knowl-
edge of the phospholipase-associated penetra-
tion mechanism from rickettsial hemolysis and
immediate cytotoxicity to a model of actual
infection, and they expand the taxonomic
groups of rickettsiae involved to include not
only the typhus group but also a pathogenic
member of the spotted fever group.
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